title: [Recurrence of Jejunal Carcinoma in the Ileum and Ovary - A Case Report].
abstract: Small bowel carcinoma has poor prognosis. The basis of treatment is surgical resection. There are no established guidelines for chemotherapy. We report a case in which we performed surgical resection of recurrent jejunal carcinoma. A 62-year-old woman underwent laparoscopic partial resection of the small intestine for primary jejunal carcinoma. The final diagnosis was T3N0M0, fStage II A. After 16 months of follow-up, she developed abdominal pain and vomiting. We diagnosed recurrence of jejunal carcinoma in the ileum and right ovary. Single-port laparoscopic small intestinal resection and right ovariectomy were performed. The patient underwent curative resection for recurrent lesions. The type of tumor in the ileum and right ovary was consistent with primary jejunal carcinoma by histopathological examination, and was diagnosed as recurrence of jejunal carcinoma. She is now on adjuvant chemotherapy with XELOX.
authors.affiliation: Dept. of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Ohara
authors.forename: Naotsugu
authors.initials: N
authors.lastname: Haraguchi
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Kudo
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Takahashi
authors.forename: Junichi
authors.initials: J
authors.lastname: Nishimura
authors.forename: Taishi
authors.initials: T
authors.lastname: Hata
authors.forename: Chu
authors.initials: C
authors.lastname: Matsuda
authors.forename: Taroh
authors.initials: T
authors.lastname: Satoh
authors.forename: Tsunekazu
authors.initials: T
authors.lastname: Mizushima
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Doki
authors.forename: Masaki
authors.initials: M
authors.lastname: Mori
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D003082:Colectomy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007078:Ileal Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D007580:Jejunal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D010052:Ovariectomy; D010071:Oxaloacetates; D012008:Recurrence
chemical_list: D010071:Oxaloacetates; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil